Last reviewed · How we verify
cisatracurium besilate
cisatracurium besilate is a Small molecule drug developed by University Hospital, Clermont-Ferrand. It is currently FDA-approved.
At a glance
| Generic name | cisatracurium besilate |
|---|---|
| Sponsor | University Hospital, Clermont-Ferrand |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Propofol Versus Sevoflurane Anesthesia on the Intraocular Pressure and Hemodynamics in Patient Undergoing Cyclophotocoagulation (NA)
- Safety and Efficacy of HRS-9190 Compared to Cisatracurium for Continuous Intravenous Infusion in Adults (PHASE2)
- Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease (PHASE4)
- Continuous Versus 1-min Oscillometric Arterial BP Monitoring (NA)
- Tubeless Spontaneous Ventilation Anesthesia in Kidney Transplantation (NA)
- Partial Neuromuscular Blockade in Acute Hypoxemic Respiratory Failure (NA)
- Differences in Speed of Recovery From Anesthesia for Intraoral Surgery (NA)
- Comparison for the Effect of Neuromuscular Blocking Agents Versus Sedation Alone on Severe ARDS Patients Due to COVID-19 (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- cisatracurium besilate CI brief — competitive landscape report
- cisatracurium besilate updates RSS · CI watch RSS
- University Hospital, Clermont-Ferrand portfolio CI
Frequently asked questions about cisatracurium besilate
What is cisatracurium besilate?
cisatracurium besilate is a Small molecule drug developed by University Hospital, Clermont-Ferrand.
Who makes cisatracurium besilate?
cisatracurium besilate is developed and marketed by University Hospital, Clermont-Ferrand (see full University Hospital, Clermont-Ferrand pipeline at /company/university-hospital-clermont-ferrand).
What development phase is cisatracurium besilate in?
cisatracurium besilate is FDA-approved (marketed).